Serum phenytoin concentrations in uremia.
作者信息
Burgess E D, Friel P N, Blair A D, Raisys V A
出版信息
Ann Intern Med. 1981 Jan;94(1):59-60. doi: 10.7326/0003-4819-94-1-59.
PMID:7004301
Abstract
摘要
相似文献
1
Serum phenytoin concentrations in uremia.尿毒症患者的血清苯妥英浓度。
Ann Intern Med. 1981 Jan;94(1):59-60. doi: 10.7326/0003-4819-94-1-59.
2
Elevated serum phenytoin concentrations in a uremic patient when measured by enzyme-multiplied immunoassay.通过酶倍增免疫测定法测得的一名尿毒症患者血清苯妥英浓度升高。
Drug Intell Clin Pharm. 1981 May;15(5):386-8. doi: 10.1177/106002808101500510.
3
Serum phenytoin concentrations in uremia.尿毒症患者的血清苯妥英浓度。
Ann Intern Med. 1981 Dec;95(6):785. doi: 10.7326/0003-4819-95-6-785_1.
4
Contribution of 5-(4-hydroxyphenyl)-5-phenylhydantoin to the discrepancy between phenytoin analyses by EMIT and high-pressure liquid chromatography.
Ther Drug Monit. 1984;6(1):97-103. doi: 10.1097/00007691-198403000-00016.
5
Interpretation of serum phenytoin concentrations in uremia is assay-dependent.尿毒症患者血清苯妥英浓度的解读取决于检测方法。
Neurology. 1984 Sep;34(9):1250-1. doi: 10.1212/wnl.34.9.1250.
6
Discrepancy in serum phenytoin concentrations determined by two immunoassay methods in uremic patients.两种免疫分析方法测定尿毒症患者血清苯妥英浓度的差异
Am J Hosp Pharm. 1985 Feb;42(2):359-61.
7
8
9
Metabolite interference in homogeneous enzyme immunoassay of phenytoin.苯妥英钠均相酶免疫分析中的代谢物干扰
Clin Chem. 1981 May;27(5):770-1.
10
Performance characteristics of four free phenytoin immunoassays.四种游离苯妥英免疫测定法的性能特征
Ther Drug Monit. 2001 Apr;23(2):148-54. doi: 10.1097/00007691-200104000-00009.
引用本文的文献
1
Phenytoin immunoassay measurements in serum samples from patients with renal insufficiency: comparison with high-performance liquid chromatography.肾功能不全患者血清样本中苯妥英免疫测定法测量结果：与高效液相色谱法的比较
J Clin Lab Anal. 2007;21(2):119-23. doi: 10.1002/jcla.20115.
2
Free level monitoring of antiepileptic drugs. Clinical usefulness and case studies.抗癫痫药物的游离水平监测。临床实用性及病例研究。
Clin Pharmacokinet. 1984 Jan;9 Suppl 1:71-8. doi: 10.2165/00003088-198400091-00009.
Zotero 插件